The influence of HLA-DRB1 alleles encoding the DERAA amino acid motif on radiological outcome in rheumatoid arthritis

Rheumatology

Volumn 38, Issue 12, 1999, Pages 1221-1227

  Mattey, D L ^a   Hassell, A B ^a   Plant, M J ^a   Cheung, N T ^a   Dawes, P T ^a   Jones, P W ^b   Thomson, W ^c   Poulton, K V ^c   Hajeer, A H ^c   Oilier, W E R ^b  

^a Staffordshire Rheumatology Centre   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

HLA DRB1; Protective alleles; Radiological outcome; Rheumatoid arthritis; Shared epitope

Indexed keywords

AMINO ACID; EPITOPE; HLA DR ANTIGEN;

ADULT; AGED; ALLELE; AMINO ACID SEQUENCE; ARTICLE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOOT RADIOGRAPHY; HAND RADIOGRAPHY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

EID: 6544295367     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.12.1221     Document Type: Article

References (38)

1. Oilier WER, MacGregor A. Genetic epidemiology of rheumatoid disease. Br Med Bull 1995;51:267-85.
2. Oilier W, Thompson W. Population genetics of rheumatoid arthritis. Rheum Dis Clin North Am 1992;18:741-59.
3. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993;364:33-9.
4. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
5. Ollier WER, Hajeer A. Does the HLA-DRB1 shared epitope really contribute that much to the development or severity of rheumatoid arthritis? In: Isenberg DA, Tucker LB, eds. Controversies in rheumatology. London: Marhn Dunitz, 1997:1-12.
6. Jaraquemada D, Oilier W, Awad J, Young A, Festenstein H. HLA and rheumatoid arthritis: susceptibility or severity? Dis Markers 1986;4:43-53.
7. Thomson W, Pepper L, Payton T et al. Absence of an association between HLA-DRB1*04 and RA in newly diagnosed cases from the community. Ann Rheum Dis 1993;52:539-41.
8. van Zeben D, Hazes JMW, Zwinderman AH, Cats A, Schreuder GMT, D'Amaro J et al. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Arthritis Rheum 1991;34: 822-30.
9. Suarez-Almazor ME, Tao S, Moustarah F, Russell AS, Maksymowych W. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid arthritis. Association with susceptibility but not severity in a city wide community based study. J Rheumatol 1995;22:2027-33.
10. Wordsworth P, Pile KD, Buckley JD, Lanchbury JSS, Oilier B, Lathrop M et al. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet 1991;51:585-91.
11. MacGregor A, Oilier W, Thomson W, Jawaheer D, Silman A. HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: Increased association in men, young age at onset and disease severity. J Rheumatol 1995;22:1032-6.
12. Larsen BA, Alderdice CA, Hawkins D, Martin JR, Mitchell DM, Sheridan DP. Protective HLA-DR phenotypes in rheumatoid arthritis. J Rheumatol 1989;16:455-8.
13. Weyand CM, Hicock KC, Conn DL, Goronzy JJ. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992;117:801-6.
14. Zanelli E, Gonzalez-Gay MA, David CS. Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol Today 1995;16:274-8.
15. Zanelli E, Krco J, Baisch M, Cheng S, David CS. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc Natl Acad Sei USA 1996;93:1814-9.
16. Zanelli E, Krco CJ, David CS. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity. Implications for rheumatoid arthritis predisposition. J Immunol 1997;158:3545-51.
17. Hassell AB, Davis MJ, Fowler PD, Clarke S, Fisher J, Shadforth MF et al. The relationship between serial measures of disease activity and outcome in rheumatoid arthritis. Q J Med 1993;86:601-7.
18. Plant MJ, Saklatvala J, Borg AA, Jones PW, Dawes PT. Measurement and prediction of radiological progression in early rheumatoid arthritis. J Rheumatol 1994;21: 1808-13.
19. Larsen A, Dale K, Eck M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol (Diagn Stockh) 1977;18: 481-91.
20. Bignon J, Fernandez-Vina M. In: Charron D, Fauchet R, eds. International histocompatibility workshop technical handbook. 12th IHWC HLA Class II reference booklet addendum 01/95. Paris, 1995.
21. Dababnch F, Farhan A, Payton A, Hajeer AH, Thomson W, Oilier WER. A comparative study of HLA-DR4 subtyping by SSCP versus sequencing-based typing and INNO-LiPA strips. Eur J Immunogenet 1997;24:70.
22. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
23. Aickin M, Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am J Public Health 1996;86:726-8.
24. Moreno I, Valenzuela A, Garcia A, Yelarnos J, Sanchez B, Hernanz W. Association of the shared epitope with radiological severity of rheumatoid arthritis. J Rheumatol 1996;23:6-9.
25. Young A, Jaraquemada D, Awad J, Festenstein H, Corbett M, Hay FC et al. Association of HLA-DR4 and DR2/Dw2 with radiologic changes in a prospective study of patients with rheumatoid arthritis. Arthritis Rheum 1984;27:20-5.
26. Olsen NJ, Callahan LF, Brooks RH et al. Association of HLA-DR4 with rheumatoid factor and radiographic severity in rheumatoid arthritis. Am J Med 1988;84:257-64.
27. Walton K, Dyer PA, Grennan DM, Haeney M, Harris R. Clinical features, auto-antibodies and HLA-DR antigens in rheumatoid arthritis. J Rheumatol 1985;12:223-6.
28. Stockman A, Emery P, Doyle T, Hopper J, Tait B, Muirden K. Relationship of progression of radiographic changes in hands and wrists, clinical features and HLA-DR antigens in rheumatoid arthritis. J Rheumatol 1991;18: 1001-7.
29. Weyand CM, McCarthy TG, Goronzy JJ. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995;95:2120-6.
30. Weyand CM, Xie C, Goronzy JJ. Homozygosity for the HLA-DRBI allele selects for extraarticular manifestations in rheumatoid arthritis. J Clin Invest 1992;89:2033-9.
31. Perdriger A, Chales G, Semana G, Guggenbuhl P, Meyer O, Quillivic F et al. Role of HLA-DR-DR and DR-DQ associations in the expression of extraarticular manifestations and rheumatoid factor in rheumatoid arthritis. J Rheumatol 1997;24:1272-6.
32. McDonagh JE, Dunn A, Oilier WER, Walker DJ. Compound heterozygosity for the shared epitope and the risk and severity of rheumatoid arthritis in extended pedigrees. Br J Rheumatol 1997;36:322-7.
33. Yasunami R, Miyamoto T, Kanda T. HLA-DRB1 is related to the pathological changes of the liver in chronic hepatitis. Hepatol Res 1997;7:3-12.
34. Hohler T, Gerken G, Notghi A, Lubjuhn R, Taheri H, Protzer U et al. HLA-DRB1*1301 and *1302 protect against chronic hepatitis. J Hepatol 1997;26:503-7.
35. Haegert DG, Swift FV, Benedikz J. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland. Neurology 1996;46:1107-11.
36. Ishihara M, Ohno S, Ishida T, Ando H, Naruse T, Nose Y et al. Molecular-genetic studies of HLA class-II alleles in sarcoidosis. Tissue Antigens 1994;43:238-41.
37. Apple RJ, Erlich HA, Klitz W, Manos MM, Becker TM, Wheeler CM. HLA DR-DQ associations with cervical carcinoma show papilloma-type specificity. Nature Genet 1994;6:157-62.
38. Chen Y, Winchester R, Korber B, Gagliano J, Bryson Y, Hutto C et al. Influence of HLA alleles on the rate of progression of vertically transmitted HIV infection in children: Association of several HLA-DR13 alleles with long-term survivorship and the potential of HLA-A*2301 with rapid progression to AIDS. Hum Immunol 1997;55:154-62.